SmartCella Receives EUR 50 Million to Boost Commercialization of mRNA Operations
SmartCella Holding has announced a new share issue raising approximately EUR 50 million to accelerate growth and support commercialization of the Extroducer and the company's cell and mRNA operations.
Extroducer | 08/07/2024 | By Aishwarya | 201
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy